Skip to content
Open access

Stroke-heart syndrome: biomarkers and in-hospital outcomes—pilot data from the SHS-PARTICLES study

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

Cardiac biomarker activation and short-term outcomes between hemorrhagic (HS) and ischaemic stroke (IS) and to identify independent predictors of length of stay (LOS) and in-hospital mortality (LOS) are compared.

Abstract

Stroke-Heart Syndrome (SHS) involves acute cardiac injury and hemodynamic stress following a cerebrovascular event. The differential magnitude of myocardial injury between hemorrhagic and non-hemorrhagic stroke and its impact on in-hospital outcomes, remains incompletely defined. To compare cardiac biomarker activation and short-term outcomes between hemorrhagic (HS) and ischaemic stroke (IS), and to identify independent predictors of length of stay (LOS) and in-hospital mortality. We analyzed 396 consecutive stroke patients in 2025. We measured NT-proBNP and high-sensitivity troponin I (Hs-TnI) at admission and at peak. We assessed left ventricular ejection fraction (LVEF), LOS, and in-hospital death. Linear regression modeled LOS; logistic regression modeled in-hospital death (per 1 unit). The study comprised patients diagnosed with IS, n=370 (mean age 73.85±13.27, 53.24% female) and HS, n=26 (mean age 74.15±10.53, 38.46% female). Baseline comorbidities including heart failure (27.84%, n=103 vs 34.62%, n=9; p=0.46), diabetes mellitus (27.03%, n=100 vs 42.31%, n=11; p=0.09), hypertension (87.30%, n=323 vs 92.31%, n=24; p=0.45), hyperlipidemia (61.62%, n=228 vs 53.85%, n=14; p=0.43), chronic coronary syndrome (14.05%, n=52 vs 7.69%, n=2; p=0.36), past myocardial infarction (7.3%, n=27 vs 0.0%, n=0; p=0.15), past stroke (9.19%, n=34 vs 15.38%, n=4; p=0.3) did not differ significantly between groups. HS demonstrated markedly grater cardiac biomarker activation: peak NT-proBNP: 10645.6±12707.3 vs 2539.8±3974.0 pg/mL (p<0.001); peak Hs-TnI: 2124.3±9778.0 vs 346.5±2806.3 ng/L (p=0.02); The proportion of patients with elevated Hs-TnI was higher in HS (69.23% vs 41.08%, p=0.005) as was >10xULN Hs-TnI (26.92% vs 10.54%, p=0.012). HS was associated with longer hospitalization (17.58±9.42 vs 7.81±3.90 days, p<0.001) and higher in-hospital mortality (19.23%, n=5 vs 4.32%, n=16, p=0.001). In linear regression, age (β=0.042, 95%CI 0.003–0.081, p=0.03) and LVEF (β=−0.084, 95%CI −0.149 to −0.019, p=0.011) were independent predictors of LOS, while peak cardiac biomarkers were not. In logistic regression for in-hospital death, age (OR 1.047 per 1-year increase, 95%CI 0.034-1.207; p=0.030), peak NT-proBNP (OR+1000pg/mL 1.117 per 1,000 pg/mL increase, 95%CI 1.034-1.207, p=0.005), peak Hs-TnI (OR+1000pg/mL1.078 per 1,000 pg/mL increase, 95%CI 1.015-1.143, p=0.014) and LVEF+5% (OR 0.737, 95% CI 0.580-0.936, p=0.012) were all predictors. HS may be associated with substantially stronger SHS activation and higher in-hospital mortality than IS. While age and LVEF predict the duration of stay, cardiac biomarkers (NT-proBNP and Hs-TnI) serve as predictors of mortality. These findings support systematic cardiac screening across stroke subtypes to identify high-risk neurocardiac phenotypes.M Chlabicz graphical abstractFor image description, please refer to the figure legend and surrounding text.

Read PDF

Similar papers

Open access Sep 2026

Distinct Determinants of Hospitalisation and In-Hospital Mortality After Acute Stroke: Insights into Stroke–Heart Syndrome (SHS-PARTICLES Study)

Cardiac and neurological abnormalities provide complementary prognostic roles after acute stroke and support integrated neurological and cardiovascular risk assessment after acute stroke.

M. Chlabicz, Magdalena Krętowska, P. Muszyński et al. · 0 citations
Open access Oct 2026

Admission high-sensitivity cardiac troponin T and clinical outcomes after acute ischemic stroke: a retrospective cohort study with exploratory nonlinear analysis

Background Elevated high-sensitivity cardiac troponin T (hs-cTnT) is frequently observed in patients with acute ischemic stroke (AIS) and has been associated with adverse outcomes. We aimed to evaluate the association of admission hs-cTnT with 90-day functional outcome and all-cause mortality during follow-up, with par...

Yi-Sheng Chen, Su-Hua Liu, Hua Xue et al. · 0 citations
Open access Oct 2026

MHR and AIP as Differential Predictors of 1-Year Major Adverse Cardiovascular and Cerebrovascular Events After Acute Ischemic Stroke: A Combined Model Study

Objective To evaluate the predictive value of monocyte-to-high-density lipoprotein cholesterol ratio (MHR), plasma atherogenic index (AIP), and baseline National Institutes of Health Stroke Scale (NIHSS) score for 1-year major adverse cardiovascular and cerebrovascular events (MACCE) after acute ischemic stroke, and to...

Zheng Liang, Wen-Xia Hu, Chi Xu et al. · 0 citations
Open access Oct 2026

Predicting recurrent hospitalizations and mortality in heart failure patients using the endothelial activation and stress index (EASIX) score

Heart failure (HF) is a major cause of mortality and morbidity, with early post-discharge readmission serving as a critical indicator of poor prognosis and high healthcare burden. Endothelial dysfunction plays a central role in HF progression and organ damage. The EASIX score (LDH X Creatinine / Platelets) is a s...

E. Eliger, Y. Granot, K. Rozenfeld et al. · 0 citations
Open access Oct 2026

Association of Baseline and Serial High-Sensitivity Cardiac Troponin T with In-Hospital Mortality Across Clinical Presentation, LVEF and Diabetes Status in Decompensated Heart Failure

Background/Objectives: High-sensitivity cardiac troponin T (hs-cTnT) is frequently elevated in decompensated heart failure (DHF), but its prognostic association may vary according to clinical context. We evaluated baseline and serial hs-cTnT in relation to in-hospital mortality across clinical presentation, left ventri...

M. Diaconu, D. Popescu, Diana Țînț et al. · 0 citations
Nov 2026

Abstract 5978: Post-Event Mortality After Stroke or Major Bleeding Across the Ejection Fraction Spectrum in Acute Heart Failure with Atrial Fibrillation

Background: Patients hospitalized with acute heart failure (AHF) and atrial fibrillation (AF) face competing risks of ischemic stroke, major bleeding, and death. Whether the mortality impact of post-stroke and post-bleeding states differs across the left ventricular ejection fraction (LVEF) spectrum, including prese...

J. Yamamoto, Keijiro Nakamura, Y. Enomoto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.